3737
vs
H
Hang Seng (Hong Kong)
3737
Over the past 12 months, Zhongzhi Pharmaceutical Holdings Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -13% compared to the Hang Seng (Hong Kong)'s +7% growth.
Stocks Performance
3737 vs Hang Seng (Hong Kong)
Performance Gap
3737 vs Hang Seng (Hong Kong)
Performance By Year
3737 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Zhongzhi Pharmaceutical Holdings Ltd
Glance View
Zhongzhi Pharmaceutical Holdings Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,152 full-time employees. The company went IPO on 2015-07-13. The firm is principally engaged in the research and development, manufacturing and sales of Chinese patent medicines and decoction pieces (consisting of traditional decoction pieces and modern decoction pieces). The firm operates through three segments: pharmaceutical manufacturing segment, operation of chain pharmacies in Zhongshan, Guangdong Province and operation of on-line pharmacies. The Company’s brands include Zeus, Liumian and Caojinghua. The firm mainly conducts its businesses in the domestic market.
